Advertisement

Medical Management of Sialorrhea in the Child with Cerebral Palsy

  • Jeremiah SabadoEmail author
  • Laura Owens
Living reference work entry

Abstract

Drooling is defined as the inability to control and swallow oral secretions resulting in unintentional loss of saliva from the mouth. This distressing condition chronically afflicts many patients with cerebral palsy and has numerous deleterious effects such as skin irritation, perioral infection, aspiration pneumonia, soiled clothing, assistive equipment damage, increased caregiver burden, lowered self-esteem, social isolation, and an overall lower quality of life. Clinical assessment and quantification of drooling are important for planning and monitoring the effectiveness of interventions. Common assessment scales include the Drooling Quotient, the Drooling Severity and Frequency Scale, and the Drooling Impact Scale. Treatment may initially involve non-pharmacologic, noninvasive methods such as behavioral modifications and oral-motor exercises. Medical therapy typically includes anticholinergic medications, such as glycopyrrolate and scopolamine patches. When conservative therapies are insufficient, direct injection of botulinum toxin into the salivary glands are frequently performed. In patients with more severe drooling that is inadequately managed with other therapies or in patients who desire more permanent solutions, a variety of surgical options are available.

Keywords

Cerebral palsy Drooling Sialorrhea Salivary glands Botulinum toxin 

References

  1. Abbas F, Farid R, Nada I et al (2013) Evaluation of ethanolamine oleate sclerotherapy on the submandibular glands of canines as a potential therapy for sialorrhea. Int J Pediatr Otorhinolaryngol 77(3):351–355.  https://doi.org/10.1016/j.ijporl.2012.11.024CrossRefPubMedGoogle Scholar
  2. Bavikatte G, Sit PL, Hassoon A (2012) Management of drooling of saliva. Br J Med Pract 5(1):a507Google Scholar
  3. Blasco P (2002) Management of drooling: 10 years after the Consortium on Drooling, 1990. Dev Med Child Neurol 44:778–781CrossRefGoogle Scholar
  4. Blasco PA, Allaire JH (1992) Drooling in the developmental disabled: management practices and recommendations. Dev Med Child Neurol 34:849–862.  https://doi.org/10.1111/j.1469-8749.1992.tb11382.xCrossRefPubMedGoogle Scholar
  5. Brodsky L (1993) Drooling in children. In: Arvedson J, Brodsky L (eds) Pediatric swallowing and feeding: assessment and management. Singular Publishing Group, New York, pp 389–416Google Scholar
  6. Burch E, Lubeley L, Murakami J (2017) Percutaneous salivary gland ablation using ethanol in a rat model. J Oral Maxil Res 8(4).  https://doi.org/10.5037/jomr.2017.8403
  7. Bushara KO (1997) Sialorrhea in amyotrophic lateral sclerosis: a hypothesis of a new treatment – botulinum toxin A injections of the parotid glands. Med Hypotheses 48(4):337–339CrossRefGoogle Scholar
  8. Camp-Bruno JA, Winsberg BG, Green-Parsons AR et al (1989) Efficacy of benztropine therapy for drooling. Dev Med Child Neurol 31:309–319CrossRefGoogle Scholar
  9. Cardona I, Saint-Martin C, Daniel SJ (2015) Effect of recurrent onabotulinum toxin A injection into the salivary glands: an ultrasound measurement. Laryngoscope 125:E328–E332CrossRefGoogle Scholar
  10. Carranza-del Rio J, Clegg NH, Moore A et al (2011) Use of trihexyphenidyl in children with cerebral palsy. Pediatr Neurol 44(3):202–206CrossRefGoogle Scholar
  11. Dias BLS, Fernandes AR, Maia HSF (2017) Treatment of drooling with sublingual atropine sulfate in children and adolescents with cerebral palsy. Arq Neuropsiquiatr 75(5):282–287.  https://doi.org/10.1590/0004-282X20170033CrossRefPubMedGoogle Scholar
  12. Ekedahl C, Hallén O (1973) Quantitative measurement of drooling. Acta Otolaryngol 75(2–6):464–469.  https://doi.org/10.3109/00016487309139776CrossRefPubMedGoogle Scholar
  13. Fairhurst CBR, Cockerill H (2011) Management of drooling in children. Arch Dis Child Educ Pract Ed 96:25–30CrossRefGoogle Scholar
  14. Gold JI, Nicolau CD, Belmont KA et al (2009) Pediatric acupuncture: a review of clinical research. Evid Based Complement Alternat Med 6(4):429–439CrossRefGoogle Scholar
  15. Heine RG, Catto-Smith AG, Reddihough DS (1996) Effect of antireflux medication on salivary drooling in children with cerebral palsy. Dev Med Child Neurol 38:1030–1036CrossRefGoogle Scholar
  16. Hurst D, Cedrone N (2006) Modafinil for drooling in cerebral palsy. J Child Neurol 21(2):112–114CrossRefGoogle Scholar
  17. Johnson HM, Reid SM, Hazard CJ et al (2004) Effectiveness of the Innsbruck Sensorimotor Activator and Regulator in improving saliva control in children with cerebral palsy. Dev Med Child Neurol 46:39–45CrossRefGoogle Scholar
  18. Jongerius PH, Rotteveel JJ, Hoogen FVD et al (2001) Botulinum toxin A: a new option for treatment of drooling in children with cerebral palsy. Presentation of a case series. Eur J Pediatr 160(8):509–512.  https://doi.org/10.1007/s004310100784CrossRefPubMedGoogle Scholar
  19. Jongerius PH, van Tiel P, van Limbeek J et al (2003) A systematic review for evidence of efficacy of anticholinergic drugs to treat drooling. Arch Dis Child 88:911–914CrossRefGoogle Scholar
  20. Khan WU, Campisi P, Nadarajah S et al (2011) Botulinum toxin A for treatment of sialorrhea in children. Arch Otolaryngol 137(4):339.  https://doi.org/10.1001/archoto.2010.240CrossRefGoogle Scholar
  21. Koheil R, Sochaniwskyj AE, Bablich K et al (1987) Biofeedback techniques and behavior modification in the conservative remediation of drooling by children with cerebral palsy. Dev Med Child Neurol 29:19–26CrossRefGoogle Scholar
  22. Lakraj A, Moghimi N, Jabbari B (2013) Sialorrhea: anatomy, pathophysiology and treatment with emphasis on the role of botulinum toxins. Toxins 5(5):1010–1031.  https://doi.org/10.3390/toxins5051010CrossRefPubMedPubMedCentralGoogle Scholar
  23. Lespargot A, Langevin MF, Muller S et al (1993) Swallowing disturbances associated with drooling in cerebral-palsied children. Dev Med Child Neurol 35:298–304CrossRefGoogle Scholar
  24. Lew KM, Younis RT, Lazar RH (1991) The current management of sialorrhea. Ear Nose Throat J 70(2): 99–105PubMedGoogle Scholar
  25. Lewis DW, Fontana C, Mehallick LK et al (1994) Transdermal scopolamine for reduction of drooling in developmentally delayed children. Dev Med Child Neurol 36:484–486CrossRefGoogle Scholar
  26. Little SA, Kubba H, Hussain SSM (2009) An evidence-based approach to the child who drools saliva. Clin Otolaryngol 34:236–239CrossRefGoogle Scholar
  27. Mato A, Limeres J, Tomas I et al (2010) Management of drooling in disabled patients with scopolamine patches. Br J Clin Pharmacol 69(6):684–688CrossRefGoogle Scholar
  28. Mier RJ, Bachrach SJ, Lakin RC et al (2000) Treatment of sialorrhoea with glycopyrrolate. Arch Pediatr Adolesc Med 154:1214–1218CrossRefGoogle Scholar
  29. Norderyd J, Graf J, Macrusson A et al (2017) Sublingual administration of atropine eyedrops in children with excessive drooling – a pilot study. Int J Paediatr Dent 27:22–29CrossRefGoogle Scholar
  30. Nunn J (2000) Drooling: review of the literature and proposals for management. J Oral Rehabil 27(9):735–743CrossRefGoogle Scholar
  31. Oliveira JB, Evêncio-Neto J, Baratella-Evêncio L (2017) Histological and immunohistochemical findings of the action of botulinum toxin in salivary gland: systematic review. Braz J Biol 77(2):251–259.  https://doi.org/10.1590/1519-6984.11115CrossRefPubMedGoogle Scholar
  32. Paneth N, Hong T, Korzeniewski S (2006) The descriptive epidemiology of cerebral palsy. Clin Perinatol 33(2): 251–267CrossRefGoogle Scholar
  33. Parkes J, Hill N, Platt MJ (2010) Oromotor dysfunction and communication impairments in children with cerebral palsy: a register study. Dev Med Child Neurol 52:1113–1119CrossRefGoogle Scholar
  34. Porte MCA, Chaléat-Valayer E, Patte K et al (2014) Relevance of intraglandular injections of Botulinum toxin for the treatment of sialorrhea in children with cerebral palsy: a review. Eur J Paediatr Neurol 18(6):649–657.  https://doi.org/10.1016/j.ejpn.2014.05.007CrossRefPubMedGoogle Scholar
  35. Proctor GB (2016) The physiology of salivary secretion. Periodontol 70(1):11–25.  https://doi.org/10.1111/prd.12116CrossRefGoogle Scholar
  36. Rapoport A (2010) Sublingual atropine drops for the treatment of pediatric sialorrhea. J Pain Symptom Manag 40(5):783–788CrossRefGoogle Scholar
  37. Rashnoo P, Daniel S (2015) Drooling quantification: correlation of different techniques. Int J Pediatr Otorhinolaryngol 79:1201–1205CrossRefGoogle Scholar
  38. Reddihough D, Erasmus CE, Johnson H et al (2010) Botulinum toxin assessment, intervention and aftercare for paediatric and adult drooling: international consensus statement. Eur J Neurol 17:109–121.  https://doi.org/10.1111/j.1468-1331.2010.03131.xCrossRefPubMedGoogle Scholar
  39. Reid SM et al (2005) Third report of the Victorian cerebral palsy register. Department of Child Development and Rehabilitation, Murdoch Children’s Research Institute, Royal Children’s Hospital, MelbourneGoogle Scholar
  40. Reid SM, Johnson HM, Reddihough DS (2010) The Drooling Impact Scale: a measure of the impact of drooling in children with developmental disabilities. Dev Med Child Neurol 52:e23–e28CrossRefGoogle Scholar
  41. Rodwell K, Edwards P, Ware RS et al (2012) Salivary gland botulinum toxin injections for drooling in children with cerebral palsy and neurodevelopmental disability: a systematic review. Dev Med Child Neurol 54(11):977–987.  https://doi.org/10.1111/j.1469-8749.2012.04370.xCrossRefPubMedGoogle Scholar
  42. Rosenbaum P, Paneth N, Leviton A et al (2007) A report: the definition and classification of cerebral palsy. Dev Med Child Neurol 49(6):8–14Google Scholar
  43. Senner JE, Logemann J, Zecker S et al (2004) Drooling, saliva production, and swallowing in cerebral palsy. Dev Med Child Neurol 46:801–806CrossRefGoogle Scholar
  44. Shiels WE (2012) Percutaneous salivary gland ablation for treatment of sialorrhea. Pediatr Radiol 42(Suppl 2):S315–S316Google Scholar
  45. Sochaniwskyj A (1982) Drool quantification: noninvasive technique. Arch Phys Med Rehabil 63(12):605–607PubMedGoogle Scholar
  46. Teymoortash A et al (2007) Intraglandular application of botulinum toxin leads to structural and functional changes in rat acinar cells. Br J Pharmacol 152: 161–167CrossRefGoogle Scholar
  47. van der Burg JJW, Didden R, Jongerius PH et al (2007) A descriptive analysis of studies on behavioural treatment of drooling (1970–2005). Dev Med Child Neurol 49:390–394CrossRefGoogle Scholar
  48. van der Burg JJW et al (2008) Behavioural treatment of drooling: a methodological critique of the literature with clinical guidelines and suggestions for future research. In: Drooling in children with cerebral palsy: impact and behavioural treatment. CIP-Data Koninlkijke Bibiotheek, Den Haag, pp 67–89Google Scholar
  49. van Hulst K, Lindeboom R, van der Burg J et al (2012) Accurate assessment of drooling severity with the 5-minute drooling quotient in children with developmental disabilities. Dev Med Child Neurol 54: 1121–1126CrossRefGoogle Scholar
  50. Walshe M, Smith M, Pennington L. Interventions for drooling in children with cerebral palsy. Cochrane Database of Systematic Reviews, July 2010.  https://doi.org/10.1002/14651858.cd008624
  51. Wong V, Sun JG, Wong W (2001) Traditional Chinese medicine (tongue acupuncture) in children with drooling problems. Pediatr Neurol 25(1):47–54CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Division of Pediatric Radiology, Department of Medical ImagingNemours/Alfred I. duPont Hospital for ChildrenWilmingtonUSA
  2. 2.Nemours/Alfred I. duPont Hospital for ChildrenWilmingtonUSA

Section editors and affiliations

  • Freeman Miller
    • 1
  • Steven J. Bachrach
    • 2
    • 3
  1. 1.AI DuPont Hospital for ChildrenWilmingtonUSA
  2. 2.Department of Pediatrics (Emeritus)Nemours/Alfred I. duPont Hospital for ChildrenWilmingtonUSA
  3. 3.Sidney Kimmel Medical College of Thomas Jefferson UniversityPhiladelphiaUSA

Personalised recommendations